NAYA Biosciences Inc
NASDAQ:NAYA

Watchlist Manager
NAYA Biosciences Inc Logo
NAYA Biosciences Inc
NASDAQ:NAYA
Watchlist
Price: 2.2 USD 8.37% Market Closed
Market Cap: 1.5m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Loading...
Revenue
Loading...
Operating Income
Loading...
Net Income
Loading...

Wall Street
Price Targets

NAYA Price Targets Summary
NAYA Biosciences Inc

Wall Street analysts forecast NAYA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NAYA is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

NAYA Lowest Forecast
Wall Street Target
6.06 USD
175% Upside
NAYA Average Forecast
Wall Street Target
6.12 USD
178% Upside
NAYA Highest Forecast
Wall Street Target
6.3 USD
186% Upside
Lowest
Price Target
6.06 USD
175% Upside
Average
Price Target
6.12 USD
178% Upside
Highest
Price Target
6.3 USD
186% Upside
NAYA Biosciences Inc Competitors:
Price Targets
1789
AK Medical Holdings Ltd
28% Upside
DXR
Daxor Corp
253% Upside
CEVI
CellaVision AB
22% Upside
L
LUCD
Lucid Diagnostics Inc
206% Upside
1789
AK Medical Holdings Ltd
28% Upside
DXR
Daxor Corp
253% Upside
CEVI
CellaVision AB
22% Upside
L
LUCD
Lucid Diagnostics Inc
206% Upside
BAX
Baxter International Inc
28% Upside
C
214150
Classys Inc
11% Upside
NYXH
Nyxoah SA
127% Upside
AGL
Angle PLC
386% Upside

Revenue
Forecast

Revenue Estimate
NAYA Biosciences Inc

For the last 8 years the compound annual growth rate for NAYA Biosciences Inc's revenue is 104%. The projected CAGR for the next 4 years is 117%.

104%
Past Growth
117%
Estimated Growth
Estimates Accuracy
3%
Average Beat
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
NAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
NAYA Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-94%
Average Miss
What are analyst estimates?

See Also

Summary
NAYA intrinsic value, competitors valuation, and company profile.
DCF Valuation
NAYA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NAYA stock valuation using valuation multiples.
Wall Street Estimates
NAYA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NAYA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NAYA's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for NAYA is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is NAYA Biosciences Inc's Revenue forecast?
Projected CAGR
117%

For the last 8 years the compound annual growth rate for NAYA Biosciences Inc's revenue is 104%. The projected CAGR for the next 4 years is 117%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 252,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.